Pharma Marketing Network

JANUARY 29, 2025

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Big data analytics plays a crucial role in identifying prescribing patterns, understanding patient behaviors, and tailoring content strategies.

Marketing 52

Marketing Compliance Big Data Branding 52

Pharma Marketing Network

OCTOBER 17, 2024

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Marketing 52

Marketing Pharma Companies Regulation Production 52

pharmaphorum

DECEMBER 22, 2021

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?

Clinical Trials 105

Clinical Trials Clinical Trials Trials Pharma Companies 105

pharmaphorum

FEBRUARY 16, 2021

They had to be nurtured and cared for, despite the fact we, as pharma companies, have very limited direct access to patients. ” What is different is that today we share cloud-based infrastructure and tools with non-pharma companies, like FMCG. Pharma has been successful because the environment is so regulated.

Marketing 103

Marketing Production Big Data Pharma Companies 103

Pharma Marketing Network

JUNE 11, 2020

And when you look through who those Twitter followers are, it’s very heavily skewed towards industry, as is the website, we’ve also put some tools on our website to be able to look at who the visitors are, by company. Don Langsdorf (EHS): 141 different pharma companies from around the world. John Mack (PG): Yeah.

Marketing 52

Marketing Branding Regulation Production 52

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52